🇺🇸 FDA

Drug profile · INN

diroximel fumarate

VUMERITY

FDA: approved EMA: approved TGA: approved L04AX07
US status
approved
Patents linked
0
News articles
0

Quick answer

diroximel fumarate (VUMERITY) is an FDA-listed pharmaceutical active ingredient. Associated with Biogen. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN diroximel fumarate
Brand VUMERITY
Route ORAL
Formulation CAPSULE, DELAYED RELEASE
ATC code L04AX07
Originator Biogen

Frequently asked questions

What is diroximel fumarate?

diroximel fumarate (VUMERITY) is an FDA-listed pharmaceutical active ingredient. Associated with Biogen. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for diroximel fumarate?

VUMERITY is a marketed brand name for diroximel fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of diroximel fumarate?

diroximel fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.